|
The Global Health Network and BSAC Establish a New Partnership
The Global Health Network and the British Society for Antimicrobial Chemotherapy (BSAC) have signed a Memorandum of Understanding (MoU) establishing a framework for collaboration that can maximise the impact of shared antimicrobial resistance education, policy and advocacy efforts.
|
|
Global Database for Tracking Antimicrobial Resistance (AMR) Country Self- Assessment Survey (TrACSS)
This database gathers crucial data on healthcare systems, regulatory frameworks, and surveillance strategies, fostering international collaboration to address the escalating challenge of AMR on a global scale.
|
|
Knocking Out AMR
This document from the Microbiology Society is a collection to serve as a central hub for the AMR content published in our portfolio. The aim is to promote feasible and effective solutions to AMR through cross-disciplinary and multi-sector collaboration worldwide.
|
|
Advocacy to Drive AMR Policy_A Country Guide
This ‘Country Guide’ provides a practical, step-by-step approach, adaptable to the country context, to: raise AMR on the policy agenda; engage and influence policy-makers; and implement AMR National Action Plans (NAPs).
|
|
People-centred approach to addressing antimicrobial resistance in human health
This document outlines the concept and content of the WHO people-centred approach to addressing antimicrobial resistance (AMR) in the human health sector.
|
|
Global research agenda for antimicrobial resistance in human health
This research agenda is global in scope and focuses on antimicrobial resistance in the human health sector, especially infections caused by the WHO bacterial priority pathogens and WHO fungal priority pathogens.
|
|
A One Health Priority Research Agenda for Antimicrobial Resistance
This research agenda is a guiding tool in One Health AMR research for investment, research activities and planning for countries and funding bodies.
|
|
Health and economic impacts of antimicrobial resistance in the Western Pacific Region, 2020–2030
This document is the first to quantify the health and economic impacts of AMR for seven priority bacteria in the Western Pacific Region, as well as model the future spread and cost implications of AMR from 2020 to 2030.
|
|
Antimicrobial resistance surveillance in Europe 2023 (2021 data)
The results presented in this report are based on antimicrobial resistance (AMR) data from invasive isolates reported to the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2022 (data referring to 2021).
|
Draft global strategy on infection prevention and control
This draft GSIPC outlines a clear vision and objectives and identifies a target audience including a wide range of key players for strategy adoption and implementation. |
Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis
This document shows the WHO prioritized list of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. |
Critically important antimicrobials for human medicine : 6th revision
This is the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. |
WHO research for hand hygiene in health care 2023–2030: summary
This agenda will provide insightful ideas for researchers to focus their projects and funding proposals and will direct donors towards the areas of hand hygiene evidence that require urgent support and innovation. |
|
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance
This document is a strategy developed by WHO to articulate the role of vaccines against AMR, a technical annex to the Immunization Agenda 2030, and an action framework that describes a vision for vaccines to contribute fully, sustainably and equitably to the prevention and control of antimicrobial resistance by preventing infections and reducing antimicrobial use.
|
|
Power Of Antibiotics
This is an initiative via which the Global Antibiotic Research and Development Partnership (GARDP) is sounding the alarm and is calling all stakeholders and people involved to help protect the power of antibiotics.
|
|
Pediatric drug optimization for antibiotics
This document is the result of the WHO's facilitated paediatric exercise for antibiotics to ensure that research and development efforts in this field target a priority list of medicines, ensuring that children with bacterial infections can also rapidly benefit from safe, effective and accessible treatment options
|
|
FAO publishes antimicrobial resistance terms in different languages
To avoid misunderstandings and inconsistent interpretations, the Food and Agriculture Organization of the United Nations (FAO) published the Antimicrobial Resistance (AMR) Terms in various languages: Arabic, Chinese, English, French, Khmer, Korean, Mongolian, Nepali, Portuguese, Russian and Spanish.
|
|
A pocket guide for ministers across sectors
This guide is developed by the Global Leaders Group on Antimicrobial Resistance to serve as a reference book for Ministers and relevant authorities based on country-specific arrangements.
|
|
Kenya national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief provides a review of the current progress on implementing the Kenya national action plan on AMR, it identifies critical gaps, and highlights findings to accelerate further progress in the human health sector.
|
|
The WHO AWaRe (Access, Watch, Reserve) antibiotic book
This antibiotic book provides concise, evidence-based guidance on the choice of antibiotic, dose, route of administration, and duration of treatment for more than 30 of the most common clinical infections in children and adults in both primary health care and hospital settings.
|
|
Global antimicrobial resistance and use surveillance system (GLASS) report: 2022
This report marks the end of the early implementation phase of GLASS. The report provides a summary of five years of national AMR surveillance data contributed to GLASS from its initiation, presents AMR findings in the context of progress of country participation in GLASS and in global AMR surveillance coverage and laboratory quality assurance systems at (sub)national level.
|
|
WHO fungal priority pathogens list to guide research, development and public health action
This list is the first global effort to systematically prioritize fungal pathogens, considering their unmet research and development (R&D) needs and perceived public health importance.
|
|
WHO Costing and Budgeting Tool for National Action Plans on Antimicrobial Resistance
The purpose of this document is to support countries in costing prioritized activities of an operational plan linked to their AMR national action plan, and identify existing funding and funding gaps to promote resource mobilization and sustainable implementation.
|
|
2022 SPECIAL REPORT: COVID-19 U.S. Impact on Antimicrobial Resistance
This special report focuses on the impact COVID-19 had on the fight against antimicrobial resistance in the United States and it calls on all stakeholders to galvanize resources to curtail the escalating spread of resistant strains in different settings.
|
|
WHO strategic priorities on antimicrobial resistance: preserving antimicrobials for today and tomorrow
This document highlights the key achievements and next steps of the WHO Antimicrobial Resistance Division at Headquarters, Geneva, indicating what has been done and areas for improvement.
|
|
Global report on infection prevention and control Executive summary
This global report on IPC provides a global situation analysis of how IPC programmes are being implemented in countries around the world and highlights the harm to patients and health workers caused by healthcare-associated infections (HAIs) and AMR.
|
